THYMOGLOBULINE

This brand name is authorized in Brazil, Ecuador, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Poland, Singapore, Tunisia, Turkey, South Africa

Active ingredients

The drug THYMOGLOBULINE contains one active pharmaceutical ingredient (API):

1 Human anti-thymocyte rabbit immunoglobulin
UNII D7RD81HE4W - LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN

Antithymocyte immunoglobulin is a selective immunosuppressive agent mostly acting on T lymphocytes. Antithymocyte immunoglobulin is used for the prevention and treatment of graft rejection after solid organ transplantation, usually in combination with other immunosuppressive drugs.

Read about Antithymocyte immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
THYMOGLOBULINE Powder for solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L04AA04 Antithymocyte immunoglobulin (rabbit) L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AA Selective immunosuppressants
Discover more medicines within L04AA04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 576720070080617
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 72-MBE-1016
Country: FR Base de données publique des médicaments Identifier(s): 62850870
Country: HR Agencija za lijekove i medicinske proizvode Identifier(s): HR-H-671425021
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 6996
Country: JP 医薬品医療機器総合機構 Identifier(s): 6399423F1026
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1015566
Country: MT Medicines Authority Identifier(s): MA596/00201
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100066697
Country: SG Health Sciences Authority Identifier(s): 03951P
Country: TN Direction de la Pharmacie et du Médicament Identifier(s): 1383021H
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699809799189
Country: ZA Health Products Regulatory Authority Identifier(s): W/30.2/75

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.